查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1777370

全球血管内导管市场

Intravascular Catheters
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 384 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血管内导管市场规模将达到 151 亿美元

全球血管内导管市场规模预计在2024年为76亿美元，到2030年将达到151亿美元，2024年至2030年的复合年增长率为12.0%。短PIVC是本报告分析的细分市场之一，预计其复合年增长率为13.4%，到分析期结束时规模将达到109亿美元。整合/封闭式PIVC细分市场在分析期间的复合年增长率预计为8.9%。

美国市场预计将达到 21 亿美元，中国市场的复合年增长率将达到 16.4%

预计到2024年，美国血管内导管市场规模将达21亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到32亿美元，在2024-2030年的分析期间内，复合年增长率为16.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为8.6%和10.8%。在欧洲，预计德国市场的复合年增长率约为9.5%。

全球血管内导管市场－主要趋势与驱动因素摘要

血管内导管将如何彻底改变医疗程序？

由于微创手术需求的不断增长、导管技术的进步以及需要血管通路的慢性疾病的日益增多，血管内导管市场正在经历显着增长。血管内导管在各种医疗应用中都至关重要，包括给药、输液、血液透析机、介入心臟病学和重症患者监护。这些导管提供安全、有效率、精准的血管通路，进而减少与传统外科手术相关的併发症。

随着全球心血管疾病 (CVD)、癌症治疗以及需要透析的末期肾功能衰竭(ESRD) 病例的增多，医院、门诊手术中心和居家医疗机构对血管内导管的应用也日益增多。此外，介入性心臟病学、神经内科和放射学的发展也扩大了专用引导管、球囊导管和微导管在血管成形术、支架置入术术和血栓切除术等精密手术中的应用。

抗菌涂层导管、生物可吸收导管和导管导航系统等技术进步改善了感染控制、病人安全和手术效率。微创治疗的兴起，加上导管相关门诊病人手术的日益普及，预计将推动市场持续扩张。

影响血管内导管市场的主要趋势有哪些？

血管内导管市场最显着的趋势之一是抗菌和肝素涂层导管的发展。导管相关性血流感染 (CLABSI) 和血栓症是长期使用导管的主要併发症，导致住院率和死亡率上升。为了应对这个问题，製造商正在推出采用银离子、洛赫西定和抗菌涂层的导管，以降低感染风险并延长导管的使用寿命。

另一个关键趋势是将智慧感测器和即时监测功能整合到导管中。配备压力感测器、无线连接和微流体技术的智慧导管能够持续监测血流动力学，早期发现阻塞并改善液体管理。这些创新非常有价值，尤其是在加护病房(ICU) 和介入性心臟病学领域，即时病患资料可以显着改善治疗效果。

周边置入中央静脉导管(PICC) 和中线导管的日益普及也正在再形成市场格局。 PICC 是长期静脉治疗中中央静脉导管(CVC) 的替代方案，可减少反覆静脉穿刺的需求。中线导管可提供中间血管通路，在门诊病人和家庭医疗保健环境中越来越受欢迎，它能够实现经济高效的长期静脉治疗，且无需承担中心静脉导管感染的风险。

另一个新兴趋势是使用生物分解性和可生物吸收的导管。传统的聚合物导管可能引起异物反应和血栓症，而生物分解性导管会随着时间的推移而溶解，从而最大限度地减少长期併发症。这项创新在需要最大程度减少残留异物的情况下尤其有益，例如临时导管置入、神经血管介入和儿科应用。

此外，介入和诊断导管手术的兴起推动了对微导管和可控导引导管的需求。这些专用器械广泛应用于血管成形术、栓塞术、介入神经放射学和电生理手术，能够在复杂的血管结构中精确导航。机器人辅助导管导航系统的日益普及，进一步提高了导管介入手术的准确性、效率和成功率。

哪些挑战正在影响血管内导管市场？

儘管血管内导管技术取得了许多进展，但仍存在一些挑战阻碍其广泛应用和市场成长。主要问题之一是导管相关感染疾病和血栓症，这可能导致严重併发症、延长住院时间并增加医疗费用。虽然抗菌涂层和先进的导管材料有助于降低感染风险，但严格的无菌技术和定期的导管维护对于预防併发症至关重要。

另一个重大挑战是先进导管设备和手术的高成本。药物释放型洗脱导管、生物可吸收导管和整合感测器的导管价格昂贵，导致低收入地区难以取得。此外，某些国家对先进导管治疗的报销有限，这可能会限制患者获得尖端治疗的机会。

监管障碍和严格的核准流程也给市场进入者带来了挑战。 FDA（美国食品药物管理局）、EMA（欧洲药品管理局）和PMDA（英国药品和医疗设备管理局）等医疗设备监管机构对新型导管技术、涂层和材料提出了严格的临床试验要求。冗长的核准流程会延迟产品上市并增加开发成本。

材料的生物相容性和导管的耐用性也是重要的考量。由硅胶、聚氨酯和PTFE（聚四氟乙烯）製成的导管必须具备最佳的柔韧性、抗扭结性和动态稳定性，以防止血栓形成和血管创伤。如何在柔软度和耐用性之间取得平衡，同时确保较低的血栓形成性，仍然是製造商面临的技术挑战。

此外，有些地区缺乏接受过高阶导管插入术训练的熟练医疗专业人员，这也是一个限制因素。介入性心臟科医师、放射科医师和血管外科医师需要接受专门训练才能执行复杂的导管插入术，而专业知识的缺乏会影响手术的成功率。

哪些因素推动了血管内导管市场的成长？

血管内导管市场的成长受到多种因素的推动，包括心血管疾病盛行率的上升、微创介入技术的兴起以及导管技术的持续创新。其中一个主要驱动因素是心血管疾病盛行率的上升，例如冠状动脉疾病 (CAD)、中风和周边动脉疾病(PAD)，这些疾病需要基于导管的介入治疗，例如血管成形术、置入术和血栓切除术。

另一个关键驱动因素是导管在肿瘤科、肾臟科和神经科的应用不断扩展。基于导管的化疗输注、用于末期肾功能衰竭(ESRD) 的透析导管以及用于中风治疗的神经血管导管正在推动市场成长。全球癌症和肾臟疾病负担的日益加重，推动了对长期血管通路设备的需求。

门诊和居家输液治疗的日益普及进一步推动了市场扩张。中央静脉导管( PICC) 和中线导管广泛用于长期抗生素化疗和肠外营养治疗，使患者能够在院外接受治疗。这一趋势在慢性病管理和老年护理领域尤其重要，因为居家静脉输液治疗可以减少住院次数和医疗成本。

机器人导管导航、即时压力感测导管和3D影像辅助导管置入等技术进步正在提高微创血管手术的准确性和安全性。基于人工智慧的导管置入引导系统的引入有助于减少併发症、改善手术效果并缩短手术时间。

此外，政府为改善血管通路护理和导管治疗基础设施所采取的措施和医疗投资也支持了市场的成长。许多新兴国家正在扩大其介入性心臟病学和透析中心，从而提升了高品质血管通路解决方案的采用率。

随着导管涂层、生物分解性材料、智慧感测器和主导影像处理的不断进步，血管内导管市场有望持续成长和创新。专注于感染控制、经济高效的解决方案和法规遵循的公司将在满足全球医疗保健提供者和患者不断变化的需求方面获得竞争优势。

部分

产品（短 PIVC、整合/封闭式PIVC）、应用（肿瘤科、胃肠科、肾臟科、感染疾病、其他）、最终用途（医院、诊所、门诊手术中心、居家医疗、其他）

受访公司范例

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company（BD）
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP31676

Global Intravascular Catheters Market to Reach US$15.1 Billion by 2030

The global market for Intravascular Catheters estimated at US$7.6 Billion in the year 2024, is expected to reach US$15.1 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2024-2030. Short PIVC, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$10.9 Billion by the end of the analysis period. Growth in the Integrated / Closed PIVC segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 16.4% CAGR

The Intravascular Catheters market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 10.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Intravascular Catheters Market - Key Trends & Drivers Summarized

How Are Intravascular Catheters Revolutionizing Medical Procedures?

The intravascular catheters market is witnessing significant growth due to increasing demand for minimally invasive procedures, advancements in catheter technology, and rising prevalence of chronic diseases requiring vascular access. Intravascular catheters are essential for a wide range of medical applications, including drug administration, fluid infusion, hemodialysis, cardiovascular interventions, and critical care monitoring. These catheters provide safe, efficient, and precise access to blood vessels, reducing complications associated with traditional surgical interventions.

With the global rise in cardiovascular diseases (CVDs), cancer treatments, and end-stage renal disease (ESRD) requiring dialysis, intravascular catheter adoption is increasing across hospitals, ambulatory surgical centers, and home healthcare settings. Additionally, the growth of interventional cardiology, neurology, and radiology has expanded the use of specialized guiding catheters, balloon catheters, and microcatheters for precision-based procedures such as angioplasty, stent placement, and thrombectomy.

Technological advancements, such as antimicrobial-coated catheters, bioabsorbable catheters, and catheter navigation systems, are enhancing infection control, patient safety, and procedural efficiency. The shift toward minimally invasive treatments, coupled with the increasing use of catheter-based therapies in outpatient settings, is expected to drive continued market expansion.

What Are the Key Trends Shaping the Intravascular Catheters Market?

One of the most notable trends in the intravascular catheters market is the development of antimicrobial and heparin-coated catheters. Catheter-associated bloodstream infections (CLABSIs) and thrombosis are major complications in long-term catheter use, leading to increased hospitalizations and mortality rates. To address this, manufacturers are introducing catheters embedded with silver-ion, chlorhexidine, and antimicrobial coatings to reduce infection risks and improve catheter longevity.

Another key trend is the integration of smart sensors and real-time monitoring capabilities in catheters. Smart catheters equipped with pressure sensors, wireless connectivity, and microfluidic technology are enabling continuous hemodynamic monitoring, early detection of blockages, and improved fluid management. These innovations are particularly valuable in intensive care units (ICUs) and interventional cardiology, where real-time patient data can significantly improve outcomes.

The increasing adoption of peripherally inserted central catheters (PICCs) and midline catheters is also reshaping the market. PICCs offer an alternative to central venous catheters (CVCs) for long-term intravenous therapy, reducing the need for repeated venipunctures. Midline catheters, which provide intermediate vascular access, are gaining traction in outpatient settings and home healthcare, enabling cost-effective, extended IV therapy without the risks associated with central line infections.

Another emerging trend is the use of biodegradable and bioresorbable catheters. Traditional polymer-based catheters can cause foreign body reactions and thrombosis, whereas biodegradable catheters dissolve over time, minimizing long-term complications. This innovation is particularly beneficial in temporary catheter placements, neurovascular interventions, and pediatric applications where minimizing residual foreign material is critical.

Additionally, the rise in interventional and diagnostic catheterization procedures is driving demand for microcatheters and steerable guiding catheters. These specialized devices are widely used in angioplasty, embolization, neurointerventions, and electrophysiology procedures, allowing precise navigation through complex vascular structures. The increasing adoption of robot-assisted catheter navigation systems is further enhancing accuracy, efficiency, and procedural success rates in catheter-based interventions.

What Challenges Are Impacting the Intravascular Catheters Market?

Despite the numerous advancements in intravascular catheter technology, several challenges hinder widespread adoption and market growth. One of the primary concerns is catheter-related infections and thrombosis, which can lead to serious complications, extended hospital stays, and increased healthcare costs. While antimicrobial coatings and advanced catheter materials help reduce infection risks, strict aseptic techniques and regular catheter maintenance are essential to prevent complications.

Another major challenge is the high cost of advanced catheterization devices and procedures. Drug-eluting catheters, bioresorbable catheters, and sensor-integrated catheters come at a premium cost, making them less accessible in low-income regions. Additionally, reimbursement limitations for advanced catheter-based procedures in certain countries can restrict patient access to cutting-edge treatments.

Regulatory hurdles and stringent approval processes pose another challenge for market players. Medical device regulatory authorities such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency, Japan) impose strict clinical trial requirements for new catheter technologies, coatings, and materials. The time-consuming approval process can delay product launches and increase development costs.

Material biocompatibility and catheter durability are also key concerns. Catheters made from silicone, polyurethane, and PTFE (polytetrafluoroethylene) must exhibit optimal flexibility, kink resistance, and hemodynamic stability to prevent clot formation and vessel trauma. Balancing softness with durability while ensuring low thrombogenicity remains a technical challenge for manufacturers.

Additionally, the shortage of skilled healthcare professionals trained in advanced catheterization procedures is a limiting factor in some regions. Interventional cardiologists, radiologists, and vascular surgeons require specialized training to handle complex catheter-based interventions, and the lack of expertise can impact procedural success rates.

What Factors Are Driving the Growth of the Intravascular Catheters Market?

The growth in the intravascular catheters market is driven by several factors, including the rising incidence of cardiovascular diseases, the increasing use of minimally invasive interventions, and continuous innovations in catheter technology. One of the major drivers is the growing prevalence of cardiovascular disorders, such as coronary artery disease (CAD), stroke, and peripheral artery disease (PAD), which require catheter-based interventions such as angioplasty, stenting, and thrombectomy.

Another key driver is the expanding applications of catheters in oncology, nephrology, and neurology. Catheter-based chemotherapy infusion, dialysis catheters for end-stage renal disease (ESRD), and neurovascular catheters for stroke treatment are contributing to market growth. The rising global burden of cancer and kidney diseases is driving demand for long-term vascular access devices.

The increasing adoption of outpatient and home-based infusion therapies is further fueling market expansion. Peripherally inserted central catheters (PICCs) and midline catheters are being widely used for long-term antibiotic therapy, chemotherapy, and parenteral nutrition, allowing patients to receive treatment outside of hospital settings. This trend is particularly significant in chronic disease management and elderly patient care, where home-based IV therapy reduces hospital admissions and healthcare costs.

Technological advancements, such as robotic-assisted catheter navigation, real-time pressure-sensing catheters, and 3D imaging-assisted catheter placement, are enhancing the precision and safety of minimally invasive vascular procedures. The introduction of AI-driven catheter placement guidance systems is helping reduce complications, improve procedural outcomes, and shorten procedure times.

Additionally, government initiatives and healthcare investments in improving vascular access care and catheter-based treatment infrastructure are supporting market growth. Many developing countries are expanding interventional cardiology and dialysis centers, increasing the adoption of high-quality intravascular catheters and vascular access solutions.

With ongoing advancements in catheter coatings, biodegradable materials, smart sensors, and AI-driven imaging, the intravascular catheters market is poised for continuous growth and innovation. Companies that focus on infection control, cost-effective solutions, and regulatory compliance will gain a competitive advantage in meeting the evolving needs of healthcare providers and patients worldwide.

SCOPE OF STUDY:

The report analyzes the Intravascular Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Short PIVC, Integrated / Closed PIVC); Application (Oncology, Gastroenterology, Renal Disease, Infectious Diseases, Others); End-Use (Hospitals, Clinics, Ambulatory Surgery Centers, Homecare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AMECATH
  • AngioDynamics, Inc.
  • Angiplast Pvt. Ltd.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company (BD)
  • Boston Scientific Corporation
  • Cook Medical
  • Edwards Lifesciences Corporation
  • Hindustan Syringes & Medical Devices Ltd.
  • ICU Medical, Inc.
  • Johnson & Johnson
  • McKesson Corporation
  • Medline Industries, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • PRODiMED
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Smiths Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravascular Catheters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Number of Hospital Admissions and ICU Stays Drives Demand for Intravascular Catheters
    • Growth in Chronic Disease Management and Long-Term Infusions Expands Market Scope
    • Increase in Chemotherapy and Parenteral Nutrition Applications Spurs Central Venous Catheter Use
    • Advancements in Catheter Materials and Antimicrobial Coatings Reduce Infection Risks and Improve Outcomes
    • Adoption of Ultrasound-Guided Insertion Techniques Strengthens Procedural Safety and Precision
    • Rising Use of Midline and PICC Catheters in Outpatient and Home Infusion Settings Enhances Access
    • Expansion of Interventional Radiology and Cardiology Procedures Fuels Specialized Catheter Demand
    • Integration With Electronic Monitoring Systems Enables Real-Time Flow and Pressure Measurement
    • Surge in Sepsis and Critical Care Cases Highlights Importance of Reliable Vascular Access
    • AI-Based Vascular Access Planning and Patient Stratification Tools Improve Catheter Placement Strategies
    • Growing Preference for Single-Use, Sterile Devices Boosts Disposable Catheter Sales
    • Increased Demand for Short Peripheral Catheters in Emergency and Ambulatory Care Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravascular Catheters Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravascular Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Short PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Short PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Integrated / Closed PIVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Integrated / Closed PIVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Renal Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Renal Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravascular Catheters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Intravascular Catheters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Intravascular Catheters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Intravascular Catheters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Intravascular Catheters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravascular Catheters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Intravascular Catheters by Product - Short PIVC and Integrated / Closed PIVC Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Intravascular Catheters by Product - Percentage Breakdown of Value Sales for Short PIVC and Integrated / Closed PIVC for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Intravascular Catheters by End-Use - Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Intravascular Catheters by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Homecare, Other End-Uses, Hospitals and Clinics for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Intravascular Catheters by Application - Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Intravascular Catheters by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Renal Disease, Infectious Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION